This platform can save clinicians significant time in creating today’s more complex, yet more beneficial, treatment plans, the company explained. ‘Incorporating leading-edge techniques for rapid and precise image fusion, VelocityAI enables automatic registration of multiple imaging modalities including CT, MR, SPECT and PET.’
The firm adds that the software enables rapid plan creation using pre-defined atlases, and advanced deformation methods support adaptive planning and complex re-treatment cases. ‘For enhanced patient follow up, VelocityAI allows volume analysis of biologic uptake of FDGPET imaging so that a more quantitative assessment of a patient’s progress can be made over time.’
Velocity recently received 510(k) clearance from the FDA to market v2.0 of VelocityAI in the USA. VelocityAI v2.0 is an updated version of the VelocityAI v1.0 product that received FDA clearance in March 2007, and added deformable image registration and atlas-based segmentation to the powerful software’s capabilities, the company explained.